We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MJ icon
426
CALL
Amplify Alternative Harvest ETF
MJ
$109M
$2K ﹤0.01%
+6,550
New +$975K
MRK icon
427
CALL
Merck
MRK
$322B
$2K ﹤0.01%
+2,096
New +$164K
CCI icon
428
CALL
Crown Castle
CCI
$31.3B
$1K ﹤0.01%
+39,800
New +$6.57M
DBRG icon
429
PUT
DigitalBridge
DBRG
$2.95B
$1K ﹤0.01%
+2,925
New +$28.3K
KMI icon
430
CALL
Kinder Morgan
KMI
$70.1B
$1K ﹤0.01%
+37,000
New +$516K
ALBO
431
PUT
DELISTED
Albireo Pharma Inc
ALBO
$1K ﹤0.01%
+35,000
New +$1.02M
AAPL icon
432
CALL
Apple
AAPL
$4.45T
– –
-300,000
Closed -$3.07M
AAPL icon
433
PUT
Apple
AAPL
$4.45T
– –
-100,000
Closed -$56K
ARKO icon
434
ARKO Corp
ARKO
$495M
– –
-39,307
Closed -$407K
BCRX icon
435
CALL
BioCryst Pharmaceuticals
BCRX
$2.64B
– –
-22,500
Closed -$2K
BPMC
436
CALL
DELISTED
Blueprint Medicines
BPMC
– –
-30,000
Closed -$276K
BWA icon
437
CALL
BorgWarner
BWA
$14.2B
– –
-131,890
Closed -$958K
CARR icon
438
CALL
Carrier Global
CARR
$52.4B
– –
-24,600
Closed -$64K
CCL icon
439
Carnival Corporation Ltd
CCL
$38B
– –
-1,476,800
Closed -$24.2M
CCL icon
440
PUT
Carnival Corporation Ltd
CCL
$38B
– –
-226,800
Closed -$2.78M
CHPT icon
441
ChargePoint
CHPT
$162M
– –
-6,348
Closed -$1.28M
CLOV icon
442
Clover Health Investments
CLOV
$2.33B
– –
-16,969
Closed -$190K
CUK
443
DELISTED
Carnival PLC
CUK
– –
-111,229
Closed -$1.4M
CVNA icon
444
PUT
Carvana
CVNA
$79.2B
– –
-75,000
Closed -$7K
CVS icon
445
CALL
CVS Health
CVS
$120B
– –
-10,000
Closed -$17K
CYTK icon
446
CALL
Cytokinetics
CYTK
$10.6B
– –
-20,400
Closed -$174K
CZR icon
447
CALL
Caesars Entertainment
CZR
$6.06B
– –
-218,700
Closed -$773K
CZR icon
448
Caesars Entertainment
CZR
$6.06B
– –
-8,930
Closed -$358K
CZR icon
449
PUT
Caesars Entertainment
CZR
$6.06B
– –
-111,200
Closed -$63K
DIS icon
450
CALL
Walt Disney
DIS
$179B
– –
-6,800
Closed -$11K
16 17
18
19 20

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.